MAGGI, Paolo
 Distribuzione geografica
Continente #
EU - Europa 16.108
AS - Asia 9.239
NA - Nord America 4.736
SA - Sud America 1.358
AF - Africa 100
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 31.550
Nazione #
RU - Federazione Russa 12.295
US - Stati Uniti d'America 4.605
SG - Singapore 3.135
CN - Cina 2.283
IE - Irlanda 2.261
HK - Hong Kong 1.624
BR - Brasile 1.162
VN - Vietnam 774
IT - Italia 716
KR - Corea 486
IN - India 456
GB - Regno Unito 200
JP - Giappone 180
DE - Germania 177
FR - Francia 102
AR - Argentina 89
BD - Bangladesh 53
NL - Olanda 51
CA - Canada 45
AT - Austria 44
UA - Ucraina 43
FI - Finlandia 40
MX - Messico 40
GR - Grecia 39
IQ - Iraq 36
CZ - Repubblica Ceca 34
ID - Indonesia 33
EC - Ecuador 27
TR - Turchia 26
CO - Colombia 24
SE - Svezia 24
MA - Marocco 21
ZA - Sudafrica 21
PL - Polonia 19
PK - Pakistan 16
PY - Paraguay 16
ES - Italia 15
VE - Venezuela 15
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 13
MY - Malesia 13
PH - Filippine 13
KE - Kenya 12
UY - Uruguay 12
TN - Tunisia 11
UZ - Uzbekistan 10
IL - Israele 9
SA - Arabia Saudita 9
AU - Australia 8
BE - Belgio 8
TH - Thailandia 8
ET - Etiopia 7
HN - Honduras 7
JO - Giordania 7
LT - Lituania 7
NP - Nepal 7
PE - Perù 7
TT - Trinidad e Tobago 7
CR - Costa Rica 6
JM - Giamaica 6
KZ - Kazakistan 6
LB - Libano 6
DZ - Algeria 5
PT - Portogallo 5
AL - Albania 4
CL - Cile 4
CM - Camerun 4
DO - Repubblica Dominicana 4
EG - Egitto 4
BG - Bulgaria 3
BH - Bahrain 3
CG - Congo 3
DK - Danimarca 3
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
OM - Oman 3
PA - Panama 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
CD - Congo 2
CH - Svizzera 2
IR - Iran 2
MD - Moldavia 2
ML - Mali 2
NI - Nicaragua 2
NO - Norvegia 2
SI - Slovenia 2
UG - Uganda 2
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
Totale 31.533
Città #
Moscow 4.330
Dublin 2.260
Hong Kong 1.617
San Jose 1.088
Santa Clara 950
Hefei 875
Singapore 837
Seoul 483
Ashburn 419
Bengaluru 350
Ho Chi Minh City 274
Hanoi 169
New York 149
Boardman 143
The Dalles 139
Chandler 135
São Paulo 100
Jacksonville 88
Dallas 83
Princeton 75
Roxbury 74
Naples 66
Los Angeles 55
Da Nang 53
Cambridge 49
Beijing 47
Falkenstein 43
Pune 41
Haiphong 40
Amsterdam 35
Brasília 35
Rio de Janeiro 32
Bremen 31
Rome 31
Medford 30
Milan 30
Nuremberg 29
Brno 27
Ann Arbor 26
Belo Horizonte 26
Munich 26
Jinan 24
Des Moines 23
Caserta 22
Vienna 22
Atlanta 21
Biên Hòa 19
Memphis 19
Curitiba 18
Guangzhou 18
Helsinki 18
Wilmington 18
Bari 17
Dhaka 17
Tokyo 17
Toronto 17
Chicago 16
Istanbul 16
Warsaw 16
Brooklyn 15
Napoli 15
Salvador 15
Changsha 14
Chennai 14
Frankfurt am Main 14
Hải Dương 14
Ninh Bình 14
Palermo 14
San Francisco 14
Shenzhen 14
Turku 14
Council Bluffs 13
Fortaleza 13
Kuala Lumpur 13
Orem 13
Porto Alegre 13
Thái Bình 13
Zhengzhou 13
Baghdad 12
Baku 12
Buenos Aires 12
Casablanca 12
Hangzhou 12
London 12
Tianjin 12
Charlotte 11
Mumbai 11
Phoenix 11
Carapicuíba 10
Guarulhos 10
Hebei 10
Johannesburg 10
Montevideo 10
Paris 10
Quito 10
Tashkent 10
Asunción 9
Bogotá 9
Campinas 9
Can Tho 9
Totale 16.223
Nome #
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 186
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 183
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 165
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 162
[Acquired immunodeficiency syndrome and pulmonary Mycobacterium xenopi infection. Role of computerized tomography] 159
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 152
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 150
BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients 147
Adipocyte differentiation of 3T3-L1 cells under TAF, TDF and INSTIs selective challenge: an in vitro model 146
Hyperglycaemia on admission to hospital and COVID-19 141
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 139
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 138
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 138
Genomic Characterization of the Emerging SARS-CoV-2 Lineage in Two Districts of Campania (Italy) Using Next-Generation Sequencing 136
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 132
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 132
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 130
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. 129
A color doppler ultrasound-based comparative study between stavudine and non-stavudine regimens in the onset of vascular lesions in HIV-1 positive patients 128
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 128
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 127
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 122
A comprehensive development agenda on tenofovir alafenamide in clinical practice 120
Archi-Prevaleat Project. A National Register of Color-Doppler Ultrasonography of the Epi-Aortic Vessels in Patients Living with HIV. 120
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study 117
Genomic Characterization of the Emerging SARS-CoV-2 Lineage in Two Districts of Campania (Italy) Using Next-Generation Sequencing 117
Dynamics of Lipid Profile in Antiretroviral-Naïve HIV-Infected Patients, Treated with TAF-Based Regimens: A Multicenter Observational Study 117
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naïve HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 116
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 115
. Prevaleat study (Premature Vascular Lesions and Antiretroviral Therapy). A comparative study between patients treated with PI-including regimens vs NNRTI-including regimens 115
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study 114
. Long term non progressors among IVDA: behavioural, clinical and virological aspects 114
. Cutaneous reactions in HIV-1 positive patients treated with enfuvirtide 114
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 114
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 114
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 113
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 112
Implications of AB0 blood group in hypertensive patients with covid-19 110
Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: A multicenter observational study 109
A Cyanobacterium-Like Body found in the stools of an HIV+ patient with diarrhoea 108
Accettabilità del condom: studio su una coorte di tossicodipendenti e loro partners 108
Weight gain in dolutegravir containing regimens in the observational SCOLTA cohort. 108
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study 108
Evaluation of lipid profile in HIV naive patients, treated by TAF-based regimens. 107
A case of human brucellosis caused by accidental injection of animal vaccine 106
Isolamento dell' HIV e antigenemia P24 105
A retrospective study on non transfusional HCV hepatitis in hemodialized patients 104
Abnormalities of abdominal wall: a case of venous displasia between external mammary common femoral veins and right iliac axis with varicocele 103
Alexithymia is linked to neurocognitive function independently of sociodemographic and clinical predictors. A multicentric HIV cohort study 103
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study. 103
Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy 102
Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control? 102
. First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006) 101
Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy 100
Squillace N, Menzaghi B, Migliorino GM, De Socio GV, Passerini S, Martinelli C, Mameli MS, Maggi P, Falasca K, Cordier L, Celesia BM, Salomoni E, Di Biagio A, Pellicanò G, Bonfanti P. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide and cholesterol increase: impact on cardiovascular risk assessment. Journal of HIV and Ageing. 99
A greater prevalence of X4 viruses in HIV type 1 intravenous drug users reflects a "CD4+ effect" 98
A nodular pulmonary lesion due to Linguatula serrata in an HV-positive man 98
Occupational risk linked to leptospirae in Apulia 97
RISK OF FAILURE IN DUAL THERAPY VERSUS TRIPLE THERAPY IN NAÏVE HIV-PATIENTS: A META-ANALYSIS 97
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study 97
A color-doppler ultrasonographic comparative study between patients treated with PI-including regimens vs NNRTI-including regimens (Prevaleat study). 97
Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens 96
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use. 95
Dolutegravir safety in a real-life setting: results Title from the SCOLTA cohort 95
Primary prophylaxis against pneumocystis carinii and Toxoplasma gondii with low dose cotrimoxazole: a case-control study 94
Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients 94
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy 92
Ruolo della diagnostica con Fibroscan nella valutazione della fibrosi epatica in pazienti HIV-positivi. Confronto tra soggetti monoinfetti versus coinfetti 92
Archi-Prevaleat project. A National Register of color-Doppler ultrasonography of the epi-aortic vessels in Patients Living with HIV. 92
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 91
Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis 91
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting 90
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 90
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 89
Cardiovascular risk assessment in antiretroviral-naive patients 88
Early markers of mitochondrial tubular injury in patients treated with tenofovir vs abacavir-including backbones. 88
HIV Effectiveness Italian Conference; HEFFICON Study Group 88
HCV infection occupational hazard at dialysis units and virus spread among relatives of dialyzed patients 88
Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project 88
Smoking habits in HIV-infected people from Italy: a cross-sectional analysis of the STOPSHIV cohort 88
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 88
Long-term efficacy and safety of switching from lamivudine+adefovir to tenofovir disoproxil fumarate in virologically suppressed patients 88
Epatite NANB in pazienti emodializzati: formulazione di un protocollo diagnostico 87
Sunscreen ingredients in plasma: a threat for drug-drug interactions and toxicity among patients living with HIV? 87
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort 87
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 86
Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience 86
Incident diabetes in course of antiretroviral therapy 85
Haart and cardiovascular toxicity: a chapter to rewrite? 85
Reazione di ipersensibilità ad abacavir associata a test HLAB5701 falsamente negativo al basale, in paziente HIV naive al trattamento antiretrovirale. 85
Safety and metabolic impact of darunaviur/cobicistat in a real-life setting. Results from the SCOLTA study cohort. 84
Citrati urinari ed escrezione di glucosaminoglicani in soggetti sani ed in pazienti con nefrolitiasi ossalocalcica recidivante 83
Utilità del dosaggio della neopterina e della P24 per la stadiazione dell' infezione da HIV 83
Movement disorders in patients with cerebral toxoplasmosis and AIDS 83
Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis. Prevalence of Human Immunodeficiency virus, Hepatitis B Virus and Hepatitis C Virus among dialysis patients. 82
Therapy with Isoprinosine in asymptomatic subjects infected by HIV 82
BONE TURN-OVER MARKERS IN HIV POSITIVE PATIENTS AFTER HAART: TENOFOVIR (TDF) plus EMTRICITABINE (FTC) plus ATAZANAVIR/RITONAVIR (ATV/R)-VS.-TDF plus FTC plus EFAVIRENZ (EFV): RESULTS OF INCA TRIAL 81
Precocious lesions of the carotid vessels in HIV-1 patients treated with protease inhibitors 81
Subclinical atherosclerosis as detected by carotid ultrasound and associations with cardiac and HIV-specific risk factors; the Archi-Prevaleat project 81
Totale 10.845
Categoria #
all - tutte 116.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022446 6 16 4 7 145 9 19 11 22 17 25 165
2022/20232.335 100 17 10 12 100 39 320 45 1.654 10 10 18
2023/20241.638 29 55 45 164 695 170 23 11 15 17 108 306
2024/20255.433 18 31 9 209 926 170 878 543 838 987 398 426
2025/202621.552 791 1.811 1.558 1.120 1.464 11.543 1.066 521 758 408 366 146
2026/202731 31 0 0 0 0 0 0 0 0 0 0 0
Totale 32.034